- Home
- VINP vs THW Comparison
VINP vs THW Comparison
Compare VINP & THW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | VINP | THW |
|---|---|---|
| Founded | 2009 | N/A |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Finance Companies |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 638.8M | 516.7M |
| IPO Year | 2020 | 2015 |
Fundamental Metrics
Financial Performance| Metric | VINP | THW |
|---|---|---|
| Price | $9.84 | $13.44 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | 63.3K | ★ 129.9K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | ★ 5.72% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $18.07 | N/A |
| Revenue Next Year | $12.74 | N/A |
| P/E Ratio | $24.41 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.20 | $10.13 |
| 52 Week High | $13.61 | $13.54 |
Technical Indicators
Market Signals| Indicator | VINP | THW |
|---|---|---|
| Relative Strength Index (RSI) | 47.73 | 70.27 |
| Support Level | $9.66 | $12.33 |
| Resistance Level | $10.88 | N/A |
| Average True Range (ATR) | 0.38 | 0.23 |
| MACD | 0.03 | 0.12 |
| Stochastic Oscillator | 30.66 | 92.16 |
Price Performance
Historical ComparisonAbout VINP Vinci Partners Investments Ltd.
Vinci Compass Investments Ltd is an alternative investment platform in Brazil offering asset management, wealth management, and financial advisory services. The company comprises of six business lines i) Global IP&S, (ii) Credit (including public & private credit, opportunistic capital solutions, and agribusiness credit), (iii) Private Equity, (iv) Equities, (v) Real Assets (including real estate, infrastructure and forestry) and (vi) Corporate Advisory.
About THW abrdn World Healthcare Fund Shares of Beneficial Interest
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.